Media coverage about Aspen Aerogels (NYSE:ASPN) has been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aspen Aerogels earned a news sentiment score of 0.16 on Accern’s scale. Accern also gave news headlines about the construction company an impact score of 47.1860481937019 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Shares of Aspen Aerogels (NYSE:ASPN) traded down 0.47% during midday trading on Friday, reaching $4.25. 33,093 shares of the company’s stock traded hands. The company’s market capitalization is $87.47 million. The stock’s 50 day moving average is $4.54 and its 200-day moving average is $4.30. Aspen Aerogels has a 52 week low of $3.61 and a 52 week high of $6.71.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Thursday, August 3rd. The construction company reported ($0.23) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.01. Aspen Aerogels had a negative return on equity of 20.95% and a negative net margin of 22.22%. The business had revenue of $25.10 million during the quarter, compared to analysts’ expectations of $24.79 million. During the same quarter last year, the business posted ($0.02) earnings per share. The business’s revenue for the quarter was down 9.4% on a year-over-year basis. On average, analysts forecast that Aspen Aerogels will post ($0.86) earnings per share for the current fiscal year.

Several equities research analysts have issued reports on ASPN shares. Zacks Investment Research raised shares of Aspen Aerogels from a “hold” rating to a “buy” rating and set a $5.25 target price on the stock in a research note on Wednesday, August 9th. Citigroup Inc. lifted their target price on shares of Aspen Aerogels from $4.50 to $4.75 and gave the stock a “neutral” rating in a research note on Tuesday, May 30th. Finally, ValuEngine cut shares of Aspen Aerogels from a “sell” rating to a “strong sell” rating in a research note on Friday, July 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $6.50.

ILLEGAL ACTIVITY WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another website, it was stolen and reposted in violation of United States & international trademark & copyright law. The original version of this news story can be accessed at

Aspen Aerogels Company Profile

Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.

Insider Buying and Selling by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Stock Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related stocks with our FREE daily email newsletter.